AP NEWS
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Oligonucleotide Synthesis - Global Market Insights & Projections to 2027 with Performance Analysis of Key Players: Thermo Fisher & Genscript - ResearchAndMarkets.com

May 20, 2019

DUBLIN--(BUSINESS WIRE)--May 20, 2019--

The “Oligonucleotide Synthesis Market to 2027- Global Analysis and Forecasts By Product, Application, End User, and Geography” report has been added to ResearchAndMarkets.com’s offering.

The global oligonucleotide synthesis market is expected to reach US$ 3,971.72 Mn in 2027 from US$ 1,584.16 Mn in 2018. The market is estimated to grow with a CAGR of 11.1% from 2019-2027.

The growth of the oligonucleotide synthesis market is primarily attributed to the increasing applications of synthesized oligonucleotides, increasing investments for synthetic biology, technological advancements genome editing tools are boosting the market over the years. However, renewed regulations for biotechnology and lack of skilled professionals in life science industry are likely to pose a negative impact on the market growth.

On the other hand, advancements in synthetic biology is likely to have a positive impact on the growth of the global oligonucleotide synthesis market in the coming years.

Oligonucleotides are used in many biological and forensic applications as sequence-specific binding agents can help in identifying presence of a specific target DNA sequence. Synthetic oligonucleotides are short stretches of single stranded DNA fragments assembled by chemical synthesis. There is hardly a field in biology in which synthetic DNA has not been used or does not have the potential to be used. Synthetic oligonucleotides are widely used in the diagnosis of human genetic diseases. Oligonucleotide probes are used to detect single base pair changes within human genome. For instance, sickle cell anemia which is caused by a transversion (A^T) within -globin gene can be analyzed with labeled oligonucleotides. The increasing applications of synthesized oligonucleotides is likely to foster the growth of market in the coming years.

Global oligonucleotide synthesis market, based on product was segmented into synthesized oligonucleotides, reagents, and equipment. In 2018, the synthesized oligonucleotides segment held a largest market share of 48.3% of the oligonucleotide synthesis market, by product. This segment is also expected to dominate the market in 2027 owing to increasing use of the product in research and diagnostic purposes. The segment is also anticipated to witness the growth at a significant rate during the forecast period, 2018 to 2027.

Global oligonucleotide synthesis market, based on application was segmented into research, diagnostics, and therapeutics. Research segment is anticipated to grow at a CAGR of 45.3% during the forecast period. The availability of funds as well as supportive government policies are expected to boost the growth of the segment during the forecast period. The segment is also expected to retain its position among the other applications during the year 2027.

Some of the major primary and secondary sources for oligonucleotide synthesis included in the report are World Health Organization (WHO), National Center for Biotechnology Information (NCBI), Association of the British Pharmaceutical Industry (ABPI), Bio-Industry Association (BIA), Defense Advanced Research Projects Agency (DARPA), Pharmaceutical Research and Manufacturers of America (PhRMA), Food & Drug Administration (FDA), International Federation of Pharmaceutical Manufacturers & Associations and others.

Key Topics Covered

1. Introduction
1.1 Scope of the Study
1.2 Report Guidance
1.3 Market Segmentation
1.3.1 Global Oligonucleotide Synthesis Market - by Product
1.3.2 Global Oligonucleotide Synthesis Market - by Application
1.3.3 Global Oligonucleotide Synthesis Market - by End User
1.3.4 Global Oligonucleotide Synthesis Market - by Geography

2. Global Oligonucleotide Synthesis Market - Key Takeaways

3. Research Methodology
3.1.1 Coverage
3.1.2 Secondary Research
3.1.3 Primary Research

4. Global Oligonucleotide Synthesis Market - Market Landscape
4.1 Overview
4.2 Pest Analysis
4.2.1 North America Pest Analysis
4.2.2 Europe Pest Analysis
4.2.3 Asia Pacific Pest Analysis
4.2.4 Middle East & Africa Pest Analysis
4.2.5 South & Central America Pest Analysis
4.3 Key Market Drivers
4.3.1 Increasing Applications of Synthesized Oligonucleotides
4.3.2 Increasing Investments For Synthetic Biology
4.3.3 Technological Advancements Genome Editing Tools
4.4 Key Market Restraints
4.4.1 Renewed Regulations For Biotechnology
4.4.2 Lack of Skilled Professionals In Life Science Industry
4.5 Key Market Opportunities
4.5.1 Collaborations - The Future of Innovation
4.6 Future Trends
4.6.1 Advancements In Synthetic Biology
4.7 Impact Analysis

5. Oligonucleotide Synthesis Market - Global Analysis
5.1 Global Oligonucleotide Synthesis Market Revenue Forecasts and Analysis
5.2 Global Oligonucleotide Synthesis Market, by Geography - Forecasts and Analysis
5.3 Performance of Key Players
5.3.1 Thermo Fisher Scientific Inc.
5.3.2 Genscript
5.4 Expert Opinions

6. Global Oligonucleotide Synthesis Market Analysis - by Product
6.1 Overview
6.2 Global Oligonucleotide Synthesis Market, by Product, 2018 & 2027 (%)
6.3 Synthesized Oligonucleotides Market
6.4 Reagents Market
6.5 Equipment Market

7. Global Oligonucleotide Synthesis Market Analysis - by Application
7.1 Overview
7.2 Global Oligonucleotide Synthesis Market, by Application, 2018 & 2027 (%)
7.3 Research Market
7.4 Diagnostics Market
7.5 Therapeutics Market

8. Global Oligonucleotide Synthesis Market Analysis - by End User
8.1 Overview
8.2 Global Oligonucleotide Synthesis Market, by End User, 2018 & 2027 (%)
8.3 Academic Research Institutes Market
8.4 Diagnostic Laboratories Market
8.5 Pharmaceutical & Biotechnology Companies Market
8.6 Other End Users Market

9. Oligonucleotide Synthesis Market Revenue and Forecasts To 2027 - Geography Analysis
9.1 North America Oligonucleotide Synthesis Market Revenue and Forecasts To 2027
9.2 Europe Oligonucleotide Synthesis Market Revenue and Forecasts To 2027
9.3 Asia Pacific Oligonucleotide Synthesis Market Revenue and Forecasts To 2027
9.4 Middle East & Africa Oligonucleotide Synthesis Market Revenue and Forecasts To 2027
9.5 South and Central America Oligonucleotide Synthesis Market Revenue and Forecasts To 2027

10. Oligonucleotide Synthesis Market -Industry Landscape
10.1 Overview
10.2 Comparative Company Analysis
10.3 Growth Strategies Done by the Companies In the Market (%)
10.4 Organic Developments
10.5 Inorganic Developments

11. Oligonucleotide Synthesis Market - Key Company Profiles
11.1 Thermo Fisher Scientific Inc.
11.2 Genscript
11.3 Synthomics Inc.
11.4 Ansa Biotechnologies Inc.
11.5 Iridia Inc.
11.6 Helixworks
11.7 Keasling Lab
11.8 Molecular Assemblies
11.9 Twist Bioscience
11.10 Evonetix
11.11 DNA Script
11.12 Nuclera Nucleics Ltd.
11.13 Camena Bio

For more information about this report visit https://www.researchandmarkets.com/r/bntvp9

View source version on businesswire.com:https://www.businesswire.com/news/home/20190520005302/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Genomics

KEYWORD: EUROPE ASIA PACIFIC NORTH AMERICA AFRICA

INDUSTRY KEYWORD: HEALTH OTHER HEALTH

SOURCE: Research and Markets

Copyright Business Wire 2019.

PUB: 05/20/2019 05:19 AM/DISC: 05/20/2019 05:18 AM

http://www.businesswire.com/news/home/20190520005302/en

All contents © copyright 2019 The Associated Press.All rights reserved.